Edaravone ameliorates the adverse effects of valproic acid toxicity in small intestine

scientific article published on 10 October 2014

Edaravone ameliorates the adverse effects of valproic acid toxicity in small intestine is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1177/0960327114554047
P698PubMed publication ID25304967

P50authorSevim TunaliQ79158075
Burçin AlevQ87141637
P2093author name stringA Yarat
E Emekli-Alturfan
L Koc-Ozturk
R Yanardag
S Oktay
T Tunali-Akbay
P2860cites workThe efficacy of edaravone (radicut), a free radical scavenger, for cardiovascular diseaseQ27015129
Psychological distress, comorbidities, and health behaviors among U.S. adults with seizures: results from the 2002 National Health Interview SurveyQ28262390
Guidelines for the Early Management of Adults With Ischemic StrokeQ28297859
Catalase in vitroQ29615710
Coagulation abnormalities and acquired von Willebrand's disease type 1 in children receiving valproic acidQ33341608
Life threatening intoxication with sodium valproateQ33489752
Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of actionQ33632141
Tissue-specific hemostasis in miceQ36241086
Oxidative stress as a mechanism of valproic acid-associated hepatotoxicityQ36673575
Sialic acids in human health and diseaseQ36908164
A comparative review of the adverse effects of anticonvulsants in children with epilepsyQ41271530
Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavengerQ41968726
Biochemical basis of sodium valproate hepatotoxicity and renal tubular disorder: time dependence of peroxidative injuryQ42549268
Nitric oxide, lipid peroxidation, and antioxidant enzyme levels in epileptic children using valproic acidQ43286981
Changes in the antioxidant system in epileptic children receiving antiepileptic drugs: two-year prospective studies.Q43711273
Alkaline phosphatase and its isoenzyme activity for the evaluation of bone metabolism in children receiving anticonvulsant monotherapyQ44088006
Plasma sialic acid and acute-phase proteins in patients with myocardial infarctionQ44194395
Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicentersQ44418044
Salivary thromboplastic activity in diabetics and healthy controlsQ44677998
Early changes in hepatic redox homeostasis following treatment with a single dose of valproic acidQ45088734
Blood levels of trace elements, electrolytes, and oxidative stress/antioxidant systems in epileptic patientsQ45187417
Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsyQ46100357
Valproic acid I: time course of lipid peroxidation biomarkers, liver toxicity, and valproic acid metabolite levels in ratsQ46461170
Tissue factor activities of streptozotocin induced diabetic rat tissues and the effect of peanut consumptionQ48124567
Effects of vitamin U (S-methyl methionine sulphonium chloride) on valproic acid induced liver injury in ratsQ48138701
An in vitro approach to assess the neurotoxicity of valproic acid-induced oxidative stress in cerebellum and cerebral cortex of young ratsQ48384147
Inhibitory effect of MCI-186, a free radical scavenger, on cerebral ischemia following rat middle cerebral artery occlusionQ48498429
Effects of Ankaferd Blood Stopper and Celox on the tissue factor activities of warfarin-treated rats.Q50965594
Serum sialic acid concentration in patients with hypertriglyceridaemia showing the Frederickson's IIB phenotypeQ51603719
P433issue6
P921main subjectedaravoneQ335099
P304page(s)654-661
P577publication date2014-10-10
P1433published inHuman & Experimental ToxicologyQ1636500
P1476titleEdaravone ameliorates the adverse effects of valproic acid toxicity in small intestine
P478volume34

Reverse relations

Q97645600Pharmacokinetic and Lipidomic Assessment of the In Vivo Effects of Parishin A-Isorhynchophylline in Rat Migraine Modelscites workP2860

Search more.